Antibe Therapeutics Inc. (ATE-X) Stock Predictions - Stockchase
WATCH LIST
1
Antibe Therapeutics Inc. (ATE-X)

ON STOCKCHASE SINCE Mar 2019

Pharma & Healthcare

Antibe Therapeutics Inc.

ATE-X

1 watching          
Join the Discussion

Antibe Therapeutics Inc. (ATE-X) SAVE Apr, 25, 2019, 4:00 am

0.35 0 (0%)

About Antibe Therapeutics Inc. (ATE-X)

Antibe Therapeutics is a Toronto-based pharmaceutical company that develops inflammation-reducing drugs based on gaseous mediator technology. Antibe was founded by John L. Wallace, also a co-founder of NicOx, the first company to develop drugs utilizing gaseous mediators. More at Wikipedia

What the experts are saying about ATE-X



  • All
  • Filtered
Signal Opinion Expert
BUY
Instead of using existing NSAIDs for arthritis and getting holes in your stomach, their drug is coated with sulfur and it is effective, even in lower doses. Phase II studies should be completed by end of year or there may even be news by end of June. He thinks it is a very sound science.
Pharma & Healthcare
0 0 0 0 0
0 comments
Instead of using existing NSAIDs for arthritis and getting holes in your stomach, their drug is coated with sulfur and it is effective, even in lower doses. Phase II studies should be completed by end of year or there may even be news by end of June. He thinks it is a very sound science.
Pharma & Healthcare
0 0 0 0 0
0 comments
Robert McWhirte

President, Selective Asset Mana...

Price Price
$0.275
Owned Owned
Yes

Showing 1 to 1 of 1 entries
Successfully Saved Company
Successfully Saved Company
1+
JOIN THE DISCUSSION
1 comments in the last 7 days